For anyone that missed it
2 points that stood out to me (they seem to be tempering market expectations)
- flexibility with product specifications
target concentrate was 6% (then mentioned 'still is') - then continues to say "not many of our competitors are punching out 6% - so there is opportunity to look at an alternative grade and get the benefit of recovery and cost".
- recoveries of >70% expected by Q4 2025
in other words, recoveries will be lower in the beginning, and for about a year or so
I felt like those 2 points were made so that the market isnt too disappointed when they release initial results as they go
I guess its to be expected, and thats why theres always mention of 'ramp up risks' etc.
For anyone that missed it2 points that stood out to me (they...
Add LTR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
81.0¢ |
Change
-0.035(4.14%) |
Mkt cap ! $1.965B | |||
| Open | High | Low | Value | Volume |
| 85.5¢ | 85.5¢ | 81.0¢ | $9.418M | 11.38M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 320584 | 81.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 82.5¢ | 33321 | 6 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| LTR (ASX) Chart |